Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.
Prieto-Peña D, Genre F, Pulito-Cueto V, Ocejo-Vinyals JG, Atienza-Mateo B, Muñoz Jiménez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galindez-Agirregoikoa E, Calvo I, Ortego Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Baldivieso-Achá JP, Blanco R, Gualillo O, Martín J, Castañeda S, López-Mejías R, Remuzgo-Martínez S, González-Gay MA. Prieto-Peña D, et al. Among authors: alvarez rivas n. Clin Exp Rheumatol. 2023 Apr;41(4):864-869. doi: 10.55563/clinexprheumatol/3cqh12. Epub 2022 Dec 5. Clin Exp Rheumatol. 2023. PMID: 36533991 Free article.
Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients.
Alvarez Rivas N, Vazquez Rodriguez TR, Miranda Filloy JA, Garcia-Porrua C, Sanchez-Andrade Fernández A. Alvarez Rivas N, et al. Reumatol Clin (Engl Ed). 2019 Jan-Feb;15(1):54-57. doi: 10.1016/j.reuma.2017.04.007. Epub 2017 May 25. Reumatol Clin (Engl Ed). 2019. PMID: 28551175 Free article. English, Spanish.
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
Calderón-Goercke M, Loricera J, Aldasoro V, Castañeda S, Villa I, Humbría A, Moriano C, Romero-Yuste S, Narváez J, Gómez-Arango C, Pérez-Pampín E, Melero R, Becerra-Fernández E, Revenga M, Álvarez-Rivas N, Galisteo C, Sivera F, Olivé-Marqués A, Álvarez Del Buergo M, Marena-Rojas L, Fernández-López C, Navarro F, Raya E, Galindez-Agirregoikoa E, Arca B, Solans-Laqué R, Conesa A, Hidalgo C, Vázquez C, Román-Ivorra JA, Lluch P, Manrique-Arija S, Vela P, De Miguel E, Torres-Martín C, Nieto JC, Ordas-Calvo C, Salgado-Pérez E, Luna-Gomez C, Toyos-Sáenz de Miera FJ, Fernández-Llanio N, García A, Larena C, Palmou-Fontana N, Calvo-Río V, Prieto-Peña D, González-Vela C, Corrales A, Varela-García M, Aurrecoechea E, Dos Santos R, García-Manzanares Á, Ortego N, Fernández S, Ortiz-Sanjuán F, Corteguera M, Hernández JL, González-Gay MÁ, Blanco R. Calderón-Goercke M, et al. Semin Arthritis Rheum. 2019 Aug;49(1):126-135. doi: 10.1016/j.semarthrit.2019.01.003. Epub 2019 Jan 5. Semin Arthritis Rheum. 2019. PMID: 30655091 Free article.
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.
Calderón-Goercke M, Castañeda S, Aldasoro V, Villa I, Prieto-Peña D, Atienza-Mateo B, Patiño E, Moriano C, Romero-Yuste S, Narváez J, Gómez-Arango C, Pérez-Pampín E, Melero R, Becerra-Fernández E, Revenga M, Álvarez-Rivas N, Galisteo C, Sivera F, Olivé-Marqués A, Álvarez Del Buergo M, Marena-Rojas L, Fernández-López C, Navarro F, Raya E, Galindez-Agirregoikoa E, Arca B, Solans-Laqué R, Conesa A, Hidalgo C, Vázquez C, Román-Ivorra JA, Loricera J, Lluch P, Manrique-Arija S, Vela P, De Miguel E, Torres-Martín C, Nieto JC, Ordas-Calvo C, Salgado-Pérez E, Luna-Gomez C, Toyos-Sáenz de Miera FJ, Fernández-Llanio N, García A, Larena C, González-Vela C, Corrales A, Varela-García M, Aurrecoechea E, Dos Santos R, García-Manzanares Á, Ortego N, Fernández S, Ortiz-Sanjuán F, Corteguera M, Hernández JL, González-Gay MÁ, Blanco R. Calderón-Goercke M, et al. Among authors: alvarez rivas n. Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):112-119. Epub 2020 May 21. Clin Exp Rheumatol. 2020. PMID: 32441643 Free article. Clinical Trial.
Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients.
Calderón-Goercke M, Castañeda S, Aldasoro V, Villa I, Moriano C, Romero-Yuste S, Narváez J, Gómez-Arango C, Pérez-Pampín E, Melero R, Becerra-Fernández E, Revenga M, Álvarez-Rivas N, Galisteo C, Sivera F, De Miguel E, Prieto-Peña D, González-Gay MÁ, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Among authors: alvarez rivas n. Semin Arthritis Rheum. 2021 Apr;51(2):387-394. doi: 10.1016/j.semarthrit.2021.01.006. Epub 2021 Jan 27. Semin Arthritis Rheum. 2021. PMID: 33607384
The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
Prieto-Peña D, Remuzgo-Martínez S, Ocejo-Vinyals JG, Atienza-Mateo B, Genre F, Muñoz-Jimenez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galindez-Agirregoikoa E, Calvo I, Ortego-Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Llorente I, García-García J, Blanco R, Gualillo O, Martin J, Castañeda S, Lopez-Mejías R, González-Gay MA. Prieto-Peña D, et al. Among authors: alvarez rivas n. Clin Exp Rheumatol. 2021 Mar-Apr;39 Suppl 129(2):21-26. doi: 10.55563/clinexprheumatol/nn15lt. Epub 2021 Mar 18. Clin Exp Rheumatol. 2021. PMID: 33734973 Free article.
Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review.
Prieto-Peña D, Bernabeu P, Vela P, Narváez J, Fernández-López JC, Freire-González M, González-Álvarez B, Solans-Laqué R, Callejas Rubio JL, Ortego N, Fernández-Díaz C, Rubio E, García-Morillo S, Minguez M, Fernández-Carballido C, de Miguel E, Melchor S, Salgado E, Bravo B, Romero-Yuste S, Salvatierra J, Hidalgo C, Manrique S, Romero-Gómez C, Moya P, Álvarez-Rivas N, Mendizabal J, Ortiz-Sanjuán F, Pérez de Pedro I, Alonso-Valdivielso JL, Perez-Sanchez L, Roldán R, Fernandez-Llanio N, Gómez de la Torre R, Suarez S, Montesa Cabrera MJ, Delgado Sánchez M, Loricera J, Atienza-Mateo B, Castañeda S, González-Gay MA, Blanco R. Prieto-Peña D, et al. Among authors: alvarez rivas n. Ther Adv Musculoskelet Dis. 2021 Jun 18;13:1759720X211020917. doi: 10.1177/1759720X211020917. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 34211589 Free PMC article.
Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals.
Prieto-Peña D, Remuzgo-Martínez S, Atienza-Mateo B, López-Mejias R, González-Gay MÁ; Spanish collaborative group for the study of large-vessel vasculitis. Prieto-Peña D, et al. Arthritis Res Ther. 2021 Oct 26;23(1):268. doi: 10.1186/s13075-021-02659-9. Arthritis Res Ther. 2021. PMID: 34702346 Free PMC article. No abstract available.
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.
Prieto-Peña D, Remuzgo-Martínez S, Genre F, Ocejo-Vinyals JG, Atienza-Mateo B, Muñoz-Jimenez A, Ortiz-Sanjuán F, Romero-Yuste S, Moriano C, Galíndez-Agirregoikoa E, Calvo I, Ortego-Centeno N, Álvarez-Rivas N, Miranda-Filloy JA, Llorente I, Blanco R, Gualillo O, Martín J, Márquez A, Castañeda S, Ferraz-Amaro I, López-Mejías R, González-Gay MA. Prieto-Peña D, et al. Among authors: alvarez rivas n. Clin Exp Rheumatol. 2022 May;40(4):727-733. doi: 10.55563/clinexprheumatol/8mku9c. Epub 2022 Mar 23. Clin Exp Rheumatol. 2022. PMID: 35349405 Free article.
14 results